After perusing info on AI startups as compiled by Crunchbase, Forbes senior contributor Louis Columbus has named one “to watch” in 2021 that serves exclusively healthcare.

The FDA’s new Digital Health Center of Excellence has released a document describing how it will henceforth oversee and evaluate software that incorporates AI and machine learning for medical applications.

The FDA has cleared UK-based Ultromics to sell an AI-powered tool for diagnosing coronary artery disease (CAD) on echocardiograms.

AI researchers and developers across the U.S. received a powerful if overshadowed shot in the arm on New Year’s Day.

Academic experts in disaster response have developed an AI-based simulation model that accurately predicts ebbs and flows in traffic at drive-through vaccination stations.

An AI application that interprets MRI scans of the brain for signs or confirmation of injury has received 510(k) clearance from the FDA.

Researchers have found that some AI models do better, on average, than expert psychiatrists at the difficult task.

Gastroenterologists need not fear being replaced by machines—and patients don’t have to worry about robot colonoscopists.